Literature DB >> 22673882

Acute kidney injury and chronic kidney disease: an integrated clinical syndrome.

Lakhmir S Chawla1, Paul L Kimmel.   

Abstract

The previous conventional wisdom that survivors of acute kidney injury (AKI) tend to do well and fully recover renal function appears to be flawed. AKI can cause end-stage renal disease (ESRD) directly, and increase the risk of developing incident chronic kidney disease (CKD) and worsening of underlying CKD. In addition, severity, duration, and frequency of AKI appear to be important predictors of poor patient outcomes. CKD is an important risk factor for the development and ascertainment of AKI. Experimental data support the clinical observations and the bidirectional nature of the relationships between AKI and CKD. Reductions in renal mass and nephron number, vascular insufficiency, cell cycle disruption, and maladaptive repair mechanisms appear to be important modulators of progression in patients with and without coexistent CKD. Distinction between AKI and CKD may be artificial. Consideration should be given to the integrated clinical syndrome of diminished GFR, with acute and chronic stages, where spectrum of disease state and outcome is determined by host factors, including the balance of adaptive and maladaptive repair mechanisms over time. Physicians must provide long-term follow-up to patients with first episodes of AKI, even if they presented with normal renal function.

Entities:  

Mesh:

Year:  2012        PMID: 22673882     DOI: 10.1038/ki.2012.208

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  277 in total

Review 1.  Remote ischemic preconditioning for kidney protection: GSK3β-centric insights into the mechanism of action.

Authors:  Zhangsuo Liu; Rujun Gong
Journal:  Am J Kidney Dis       Date:  2015-08-10       Impact factor: 8.860

Review 2.  Cellular and Molecular Mechanisms of AKI.

Authors:  Anupam Agarwal; Zheng Dong; Raymond Harris; Patrick Murray; Samir M Parikh; Mitchell H Rosner; John A Kellum; Claudio Ronco
Journal:  J Am Soc Nephrol       Date:  2016-02-09       Impact factor: 10.121

3.  Impact of AKI on Urinary Protein Excretion: Analysis of Two Prospective Cohorts.

Authors:  Chi-Yuan Hsu; Raymond K Hsu; Kathleen D Liu; Jingrong Yang; Amanda Anderson; Jing Chen; Vernon M Chinchilli; Harold I Feldman; Amit X Garg; Lee Hamm; Jonathan Himmelfarb; James S Kaufman; John W Kusek; Chirag R Parikh; Ana C Ricardo; Sylvia E Rosas; Georges Saab; Daohang Sha; Edward D Siew; James Sondheimer; Jonathan J Taliercio; Wei Yang; Alan S Go
Journal:  J Am Soc Nephrol       Date:  2019-06-24       Impact factor: 10.121

4.  Safety of a Restrictive versus Liberal Approach to Red Blood Cell Transfusion on the Outcome of AKI in Patients Undergoing Cardiac Surgery: A Randomized Clinical Trial.

Authors:  Amit X Garg; Neal Badner; Sean M Bagshaw; Meaghan S Cuerden; Dean A Fergusson; Alexander J Gregory; Judith Hall; Gregory M T Hare; Boris Khanykin; Shay McGuinness; Chirag R Parikh; Pavel S Roshanov; Nadine Shehata; Jessica M Sontrop; Summer Syed; George I Tagarakis; Kevin E Thorpe; Subodh Verma; Ron Wald; Richard P Whitlock; C David Mazer
Journal:  J Am Soc Nephrol       Date:  2019-06-20       Impact factor: 10.121

Review 5.  Controversies on the origin of proliferating epithelial cells after kidney injury.

Authors:  Tetsuro Kusaba; Benjamin D Humphreys
Journal:  Pediatr Nephrol       Date:  2013-12-10       Impact factor: 3.714

Review 6.  Normoalbuminuric diabetic kidney disease.

Authors:  Chao Chen; Chang Wang; Chun Hu; Yachun Han; Li Zhao; Xuejing Zhu; Li Xiao; Lin Sun
Journal:  Front Med       Date:  2017-07-18       Impact factor: 4.592

Review 7.  Slit2-Robo signaling in inflammation and kidney injury.

Authors:  Swasti Chaturvedi; Lisa A Robinson
Journal:  Pediatr Nephrol       Date:  2014-04-29       Impact factor: 3.714

Review 8.  Fluid management for the prevention and attenuation of acute kidney injury.

Authors:  John R Prowle; Christopher J Kirwan; Rinaldo Bellomo
Journal:  Nat Rev Nephrol       Date:  2013-11-12       Impact factor: 28.314

Review 9.  Angiogenesis and hypoxia in the kidney.

Authors:  Tetsuhiro Tanaka; Masaomi Nangaku
Journal:  Nat Rev Nephrol       Date:  2013-03-05       Impact factor: 28.314

10.  Pyridoxamine reduces postinjury fibrosis and improves functional recovery after acute kidney injury.

Authors:  Nataliya I Skrypnyk; Paul Voziyan; Haichun Yang; Christian R de Caestecker; Marie-Claude Theberge; Mathieu Drouin; Billy Hudson; Raymond C Harris; Mark P de Caestecker
Journal:  Am J Physiol Renal Physiol       Date:  2016-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.